Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;4(6):e2114716.
doi: 10.1001/jamanetworkopen.2021.14716.

Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden

Annelie Johansson  1 , Athanasia E Christakou  1 , Adina Iftimi  2 , Mikael Eriksson  3 , Jose Tapia  3 , Lambert Skoog  1 , Christopher C Benz  4   5 , Kenny A Rodriguez-Wallberg  1   6 , Per Hall  3   7 , Kamila Czene  3 , Linda S Lindström  1
Affiliations

Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden

Annelie Johansson et al. JAMA Netw Open. .

Abstract

Importance: Benign breast diseases (BBDs) are common and associated with breast cancer risk, yet the etiology and risk of BBDs have not been extensively studied.

Objective: To investigate the risk of BBDs by age, hormonal factors, and family history of breast cancer.

Design, setting, and participants: This retrospective cohort study assessed 70 877 women from the population-based Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) who attended mammographic screening or underwent clinical mammography from January 1, 2011, to March 31, 2013, at 4 Swedish hospitals. Participants took part in a comprehensive questionnaire on recruitment. All participants had complete follow-up through high-quality Swedish national registers until December 31, 2015. Pathology medical records on breast biopsies were obtained for the participants, and BBD subtypes were classified according to the latest European guidelines. Analyses were conducted from January 1 to July 31, 2020.

Exposures: Hormonal risk factors and family history of breast cancer.

Main outcomes and measures: For each BBD subtype, incidence rates (events per 100 000 person-years) and multivariable Cox proportional hazards ratios (HRs) with time-varying covariates were estimated between the ages of 25 and 69 years.

Results: A total of 61 617 women within the mammographic screening age of 40 to 69 years (median age, 53 years) at recruitment with available questionnaire data were included in the study. Incidence rates and risk estimates varied by age and BBD subtype. At premenopausal ages, nulliparity (compared with parity ≥3) was associated with reduced risk of epithelial proliferation without atypia (EP; HR, 0.62; 95% CI, 0.46-0.85) but increased risk of cysts (HR, 1.38; 95% CI, 1.03-1.85). Current and long (≥8 years) oral contraceptive use was associated with reduced premenopausal risk of fibroadenoma (HR, 0.65; 95% CI, 0.47-0.90), whereas hormone replacement therapy was associated with increased postmenopausal risks of epithelial proliferation with atypia (EPA; HR, 1.81; 95% CI, 1.07-3.07), fibrocystic changes (HR, 1.60; 95% CI, 1.03-2.48), and cysts (HR, 1.98; 95% CI, 1.40-2.81). Furthermore, predominantly at premenopausal ages, obesity was associated with reduced risk of several BBDs (eg, EPA: HR, 0.31; 95% CI, 0.17-0.56), whereas family history of breast cancer was associated with increased risk (eg, EPA: HR, 2.11; 95% CI, 1.48-3.00).

Conclusions and relevance: These results suggest that the risk of BBDs varies by subtype, hormonal factors, and family history of breast cancer and is influenced by age. Better understanding of BBDs is important to improve the understanding of benign and malignant breast diseases.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Flow Diagram of the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) Cohort and Benign Breast Diseases (BBDs)
Figure 2.
Figure 2.. Age Incidences of Benign Breast Diseases (BBDs) in the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) Cohort
Incidence rates (events per 100 000 person-years) were estimated for the BBDs in the KARMA cohort between the ages of 25 and 69 years.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev. 1997;19(2):310-327. doi:10.1093/oxfordjournals.epirev.a017960 - DOI - PubMed
    1. Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat. 1985;6(1):5-36. doi:10.1007/BF01806008 - DOI - PubMed
    1. Cole P, Mark Elwood J, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol. 1978;108(2):112-120. doi:10.1093/oxfordjournals.aje.a112594 - DOI - PubMed
    1. Fleming NT, Armstrong BK, Sheiner HJ. The comparative epidemiology of benign breast lumps and breast cancer in Western Australia. Int J Cancer. 1982;30(2):147-152. doi:10.1002/ijc.2910300204 - DOI - PubMed
    1. Hislop TG, Elwood JM. Risk factors for benign breast disease: a 30-year cohort study. CMAJ. 1981;124(3):283-291. - PMC - PubMed

Publication types

Substances